BetterMe Rx Review
Best for: patients who value pharmacy transparency — six named compounding partners
BetterMe Rx offers compounded semaglutide ($199/mo) and tirzepatide ($299/mo) in both injectable and oral daily tablet formats. LegitScript verified. All 50 states. Six named pharmacy partners with phone numbers — strongest pharmacy transparency in the dataset.
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
BetterMe Rx is a solid telehealth option with balanced features and pricing.
BetterMe Rx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo (3-month plan $597 sale price (regular $747 = $249/mo). Headline $199/mo is sale-dependent.)
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored BetterMe Rx
Each dimension is scored algorithmically from BetterMe Rx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.9/10At $199/mo, BetterMe Rx runs about 17% above the $170 median for GLP-1 providers.
Effectiveness25%
8.5/10BetterMe Rx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.2/10Online intake and platform experience; 5 platform features disclosed.
Trust & Safety15%
8.1/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
8.6/10BetterMe Rx treats patients in all 50 states.
Support10%
6.2/10BetterMe Rx provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this BetterMe Rx review
Last checked 2026-06-06- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in all 50 states
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications BetterMe Rx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
3-month plan $597 sale price (regular $747 = $249/mo). Headline $199/mo is sale-dependent.
Sale-dependent; oral price not individually re-fetched 2026-06-06 (sitewide sale applies).
3-month plan $897 sale price (regular $1,047 = $349/mo). Headline $299/mo is sale-dependent.
Sale-dependent; oral price not individually re-fetched 2026-06-06 (sitewide sale applies).
Ready to get started?
Plans and promotions change often — check BetterMe Rx's current pricing and active discounts before you decide.
What we like
- LegitScript verified
- All 50 states coverage
- Six named pharmacy partners with phone numbers — exceptional transparency
- Both injectable and oral daily tablet formats for sema and tirz
- Multi-month discounts (3-month and 6-month plans)
- Affiliated with Telegra MD and Dr Telx telehealth networks
Watch-outs
- No formal corporate entity name or address disclosed
- Compounded only — no brand-name options
- Broader platform (HRT, ED, NAD+, Sermorelin, skincare)
- Headline $199/$299 are limited-time SALE prices; regular prices are $249/$349 per month
BetterMe Rx: the rare provider that names its pharmacies
Most compounded GLP-1 sellers keep their supply chain a black box. You pay, a vial shows up, and you have no idea which facility actually mixed your medication. BetterMe Rx is the exception. It lists six named compounding pharmacies by city, with phone numbers you can call — EpiqScripts in Richardson, Texas; Valiant RX in Ypsilanti, Michigan; GoGoMeds in Southgate, Kentucky; The Pharmacy Hub in Miami; Emerald Compounding in Tampa; and Belmar Pharmacy out of Odessa, Florida. That level of disclosure is the single best reason to consider this provider, and it's why we flag it as best for patients who care about pharmacy transparency.
If you want to verify exactly where your shot is coming from before you inject it, BetterMe Rx hands you that information up front instead of hiding behind a generic "licensed U.S. pharmacy" line. For a category where trust is the whole ballgame, that matters.
What you actually pay (and why the headline number has an asterisk)
BetterMe Rx sells semaglutide and tirzepatide on multi-month plans rather than a flat monthly subscription. Compounded semaglutide works out to $199 a month on the three-month plan, and tirzepatide runs about a hundred dollars more — just under three hundred dollars a month on the same plan. Both come in either a weekly injectable or a daily oral tablet, so needle-averse patients have a real alternative here.
Here's the catch worth reading twice: those are sale prices, not the standing rate. The regular price is higher on both drugs — closer to two-fifty a month for semaglutide and three-fifty for tirzepatide once the promotion ends. BetterMe Rx runs a recurring "save on your first order" banner, so whether you actually pay the advertised number depends on the sale being live when you check out. Read the plan total before you commit, because the price is quoted as a lump sum for three or six months, not as a tidy monthly bill.
For context, the category median sits around $170 a month, so BetterMe Rx's semaglutide is priced right in the middle of the pack — not the cheapest, not gouging.
Injectable or oral, semaglutide or tirzepatide
- Compounded semaglutide — weekly injection or daily oral tablet
- Compounded tirzepatide — weekly injection or daily oral tablet
- Three-month and six-month plans, with bigger per-month savings on the longer commitment
- No brand-name Wegovy, Ozempic, Mounjaro, or Zepbound — this is compounded medication only
Coverage, telehealth, and who's behind the prescription
BetterMe Rx serves patients in all 50 states, which is broader than a lot of compounders that quietly skip the stricter regulatory states. The clinical side runs through two affiliated telehealth networks, Telegra MD and Dr Telx, and medication is only prescribed after a consultation with a licensed provider who confirms you're eligible. So there is a real prescriber gate — it's not a vending machine.
The platform itself is broader than weight loss. BetterMe Rx also sells hormone therapy, ED treatment, NAD+, Sermorelin, and skincare. That's neither good nor bad on its own, but it tells you this is a general telehealth storefront that added GLP-1s, not a dedicated metabolic-health clinic. If you want a team that lives and breathes weight management, this isn't that.
The honest drawbacks
The same company that's unusually open about its pharmacies is unusually quiet about itself. There is no corporate entity name or business address disclosed anywhere we could find. That's an odd asymmetry — you can call the pharmacy that compounds your drug, but you can't easily identify the company taking your payment. For a recurring medical purchase, that's a legitimate reason for caution.
- No formal corporate entity or physical address published
- Compounded only — if you specifically want FDA-approved brand-name medication, look elsewhere
- Headline pricing is sale-dependent; the regular rate is meaningfully higher
- Weight loss is one product line on a broad platform, not the core focus
Trust and safety: verified, with a caveat
On the credentials front, BetterMe Rx is LegitScript verified, the certification that screens telehealth and pharmacy operations for legitimacy — a meaningful signal that this isn't a fly-by-night seller. We found no FDA warning letters on file. Combined with the named, callable pharmacy partners and the licensed-prescriber requirement, the safety basics are genuinely in place.
The honest tension is the missing corporate disclosure. The medication supply chain is transparent; the company operating the store is not. You can weigh that for yourself, and our scoring methodology accounts for both the strong pharmacy transparency and the weak corporate transparency rather than letting one cancel the other.
Bottom line
BetterMe Rx is a solid mid-priced compounded GLP-1 option with one standout virtue: it tells you exactly which pharmacies make your medication. If you've been burned by vague sourcing elsewhere, or you simply want to call the compounding pharmacy before you trust an injection, this provider earns a real look — and the oral-tablet option is a bonus if you'd rather skip needles. Just go in with eyes open: confirm whether the sale price is actually live, expect a lump-sum plan rather than a monthly charge, and accept that you're buying from a broad telehealth platform that won't name its own corporate parent. For transparency-minded patients comfortable with compounded medication, it's a credible pick. For anyone who wants brand-name drugs or a fully identifiable company on the other end, keep shopping.
For a side-by-side, RNK Health ($197/month) and Breeze Meds ($199/month) are the most comparable options to weigh against BetterMe Rx.
Ready to start with BetterMe Rx?
Starting at $199/month. See current pricing and start your free consultation.
BetterMe Rx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to BetterMe Rx
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this BetterMe Rx review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with BetterMe Rx?
Starting at $199/month. See current pricing and start your free consultation.